William A. Haseltine, Contributor

Author's posts

Unraveling Hope For Prion Disease And Other Progressive Neurodegenerative Diseases

Prion diseases are rare, deadly neurodegenerative brain diseases that result from misfolding protein. Recent study encourages the development of antibodies to PrPC to prevent its conversion to PrPSc. If successful, their unique approach illuminates tre…

Study Finds Previous Covid-19 Infection Doesn’t Protect Children From Omicron

A new study found that less than 10 percent of children who contracted Covid-19 in 2020 or early 2021 developed neutralizing antibody titers against the Omicron variant of SARS-CoV-2.

Rabbitpox: the Story of a Specialized Killer

With poxviruses now back on the radar, we must consider the outstanding threat of possible human pathogens in much greater detail. It is critically important to understand not only how poxviruses jump from one species to another but also how they evolv…

Tick-Borne Disease Part II: Crimean-Congo Hemorrhagic Fever

At present there is a serious outbreak in Iraq of Crimean-Congo Hemorrhagic Fever, a rare but deadly tick-borne disease.

The Vaccinia Virus That Hopped From Rabbits to Hares

Poxviruses are back, and it is no surprise. Researchers have long predicted that halting smallpox vaccinations would enable the emergence of new virulent strains of this and other infectious poxviruses.

Expelling Covid: It Takes Longer Than You May Think

Recent study suggests that viral mRNA from SARS-CoV-2 may be found in the stools of patients diagnosed with Covid-19, even after respiratory symptoms subside. Findings suggest Covid-19 likely leads to prolonged gastrointestinal (GI) infections.

The Growing Threat Of Tick-Borne Disease Part I: Powassan Virus

Due to the combination of an incredibly short transmission time and the severity of the neurological symptoms of the resulting illness, Powassan virus is a growing threat to public health and safety throughout the range of the blacklegged tick.

FDA Turns Down Fluvoxamine Emergency Use Authorization Request

The Food and Drug Administration denied an emergency use authorization for fluvoxamine as a SARS-CoV-2 antiviral.

Predisposition Of Serious Disease Is Different For Old And Young Adults

A retrospective study examines more than 6900 medical records, correlating the effects of age, comorbidities, and the severity of symptoms from contracting SARS-CoV-2.

A Dynamic Duo: How ACE-2 And CD147 Mediate Covid-19 Infection In The Kidneys

Why are the kidneys so vulnerable to viral infection? This second part of our two-part series takes a deeper look at how the expression of CD147 and ACE-2 receptors mediates the infection of a specialized group of kidney cells: podocytes.